Sino-Biocan
Shanghai, China · Founded 2013
- Headquarters
- Shanghai
- Founded
- 2013
- Business Model
- B2B
- Website
- en.sinobiocan.net
- Last Round
- AngelMar 2024
- Rounds
- 3
About
Shanghai-based developer of GMP-grade cell preparation tools and reagents for cellular and gene therapy.
Summary
Sino-Biocan is a Biotech company based in Shanghai, China, founded in 2013. Its most recent funding was an Angel round in Mar 2024. Investors include Sinovation Ventures and Grand Flight Investment.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...